Finance

Lists
ILA:ASX
Island Pharmaceuticals Ltd
A$0.49
+6.52%
(+0.030) 1D
Aug 21, 4:10:30 PM GMT+10  ·   AUD
All symbols
SymbolPriceChange% Change
Generating top insights for ILA...
Open
A$0.46
High
A$0.50
Low
A$0.46
Mkt. cap
145.09M
Avg. vol.
233.87K
Volume
712.01K
52-wk high
A$0.63
52-wk low
A$0.20
EPS
-A$0.03
Shares outstanding
296.10M
Open
A$0.46
High
A$0.50
Low
A$0.46
Mkt. cap
145.09M
Avg. vol.
233.87K
Volume
712.01K
52-wk high
A$0.63
52-wk low
A$0.20
EPS
-A$0.03
Shares outstanding
296.10M
News stories
From web sources and news partners
About Island Pharmaceuticals Ltd
CEO-
Employees-
Founded2017
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in AUD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in AUD
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
11.03K
11.03K
20.39K
20.39K
Cost of goods sold
349.50K
349.50K
674.76K
674.76K
Cost of revenue
349.50K
349.50K
674.76K
674.76K
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
745.61K
745.61K
594.64K
594.64K
Operating expense
885.48K
885.48K
1.80M
1.80M
Total operating expenses
1.23M
1.23M
2.48M
2.48M
Operating income
-1.22M
-1.22M
-2.46M
-2.46M
Other non operating income
-
-
-
-
EBT including unusual items
-1.19M
-1.19M
-2.41M
-2.41M
EBT excluding unusual items
-1.19M
-1.19M
-2.41M
-2.41M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-1.19M
-1.19M
-2.41M
-2.41M
Net profit margin
-10,815.29%
-10,815.29%
-11,797.12%
-11,797.12%
Earnings per share
-
-
-
-
Interest and investment income
29.24K
29.24K
54.50K
54.50K
Interest expense
-
-
-
-
Net interest expenses
29.24K
29.24K
54.50K
54.50K
Depreciation and amortization charges
-
-
26.32K
26.32K
EBITDA
-
-
-2.43M
-2.43M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
AI content may include mistakes. Learn more
Google apps